3-DIMENSIONAL STRUCTURE OF HUMAN BASIC FIBROBLAST GROWTH-FACTOR

被引:278
作者
ERIKSSON, AE
COUSENS, LS
WEAVER, LH
MATTHEWS, BW
机构
[1] UNIV OREGON, HOWARD HUGHES MED INST, EUGENE, OR 97403 USA
[2] CHIRON CORP, EMERYVILLE, CA 94608 USA
[3] PROTOS CORP, EMERYVILLE, CA 94608 USA
关键词
INTERLEUKIN-1-BETA; RECEPTOR; HEPARIN BINDING SITE;
D O I
10.1073/pnas.88.8.3441
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
The three-dimensional structure of human basic fibroblast growth factor (bFGF) has been determined by x-ray crystallography and refined to a crystallographic residual of 17.4% at 2.2-angstrom resolution. The structure was initially solved at a nominal resolution of 2.8 angstrom by multiple isomorphous replacement using three heavy-atom derivatives. Although the map clearly showed the overall fold of the molecule, electron density was not observed for the first 19 amino-terminal and the last 3 carboxyl-terminal amino acids, suggesting that they are disordered. The bFGF crystals were grown from 2.0 M ammonium sulfate at pH 8.1 in space group P1 with cel' dimensions a = 30.9 angstrom, b = 33.4 angstrom, c = 35.9 angstrom,alpha = 59.5-degrees, beta = 72.0-degrees, and gamma = 75.6-degrees. There is one molecule per unit cell and the crystals diffract to spacings beyond 1.9 angstrom. The overall structure of bFGF can be described as a trigonal pyramid with a fold very similar to that reported for interleukin 1-beta, interleukin 1-alpha, and soybean trypsin inhibitor. An apparent sulfate ion is bound within a basic region on the surface of the molecule and has as ligands the main-chain amide of Arg-120 and the side chains of Asn-27, Arg-120, and Lys-125. This is suggested as the presumed binding site for heparin. Residues 106-115, which are presumed to bind to the bFGF receptor [Baird, A., Schubert, D., Ling, N. & Guillemin, R. (1988) Proc. Natl. Acad. Sci. USA 85, 2324-2328], include an irregular loop that extends somewhat from the surface of the protein and is about 25 angstrom from the presumed heparin binding site. The backbone structure of this putative receptor-binding loop is very similar, although not identical, to the corresponding region of interleukin 1-beta.
引用
收藏
页码:3441 / 3445
页数:5
相关论文
共 55 条
[1]
HUMAN BASIC FIBROBLAST GROWTH-FACTOR - NUCLEOTIDE-SEQUENCE AND GENOMIC ORGANIZATION [J].
ABRAHAM, JA ;
WHANG, JL ;
TUMOLO, A ;
MERGIA, A ;
FRIEDMAN, J ;
GOSPODAROWICZ, D ;
FIDDES, JC .
EMBO JOURNAL, 1986, 5 (10) :2523-2528
[2]
CHARACTERIZATION OF A CYSTEINE-FREE ANALOG OF RECOMBINANT HUMAN BASIC FIBROBLAST GROWTH-FACTOR [J].
ARAKAWA, T ;
HSU, YR ;
SCHIFFER, SG ;
TSAI, LB ;
CURLESS, C ;
FOX, GM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (01) :335-341
[3]
RECEPTOR-BINDING AND HEPARIN-BINDING DOMAINS OF BASIC FIBROBLAST GROWTH-FACTOR [J].
BAIRD, A ;
SCHUBERT, D ;
LING, N ;
GUILLEMIN, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (07) :2324-2328
[4]
BARR PJ, 1988, J BIOL CHEM, V263, P16471
[5]
AN ONCOGENE ISOLATED BY TRANSFECTION OF KAPOSIS-SARCOMA DNA ENCODES A GROWTH-FACTOR THAT IS A MEMBER OF THE FGF FAMILY [J].
BOVI, PD ;
CURATOLA, AM ;
KERN, FG ;
GRECO, A ;
ITTMANN, M ;
BASILICO, C .
CELL, 1987, 50 (05) :729-737
[6]
BRENNAN RG, 1989, J BIOL CHEM, V264, P1903
[7]
THE HEPARIN-BINDING (FIBROBLAST) GROWTH-FACTOR FAMILY OF PROTEINS [J].
BURGESS, WH ;
MACIAG, T .
ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 :575-606
[8]
HEPARIN POTENTIATES THE ACTION OF ACIDIC FIBROBLAST GROWTH-FACTOR BY PROLONGING ITS BIOLOGICAL HALF-LIFE [J].
DAMON, DH ;
LOBB, RR ;
DAMORE, PA ;
WAGNER, JA .
JOURNAL OF CELLULAR PHYSIOLOGY, 1989, 138 (02) :221-226
[9]
POTENTIAL ONCOGENE PRODUCT RELATED TO GROWTH-FACTORS [J].
DICKSON, C ;
PETERS, G .
NATURE, 1987, 326 (6116) :833-833
[10]
CLONING AND EXPRESSION OF 2 DISTINCT HIGH-AFFINITY RECEPTORS CROSS-REACTING WITH ACIDIC AND BASIC FIBROBLAST GROWTH-FACTORS [J].
DIONNE, CA ;
CRUMLEY, G ;
BELLOT, F ;
KAPLOW, JM ;
SEARFOSS, G ;
RUTA, M ;
BURGESS, WH ;
JAYE, M ;
SCHLESSINGER, J .
EMBO JOURNAL, 1990, 9 (09) :2685-2692